Scott Dreyer - Feb 12, 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer
Stock symbol
COLL
Transactions as of
Feb 12, 2024
Transactions value $
-$1,000,553
Form type
4
Date filed
2/14/2024, 04:14 PM
Previous filing
Jan 18, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +35K +31.44% $0.00 146K Feb 12, 2024 Direct F1
transaction COLL Common Stock Award $0 +32.3K +22.07% $0.00 179K Feb 12, 2024 Direct F2
transaction COLL Common Stock Tax liability -$659K -19.5K -10.94% $33.70 159K Feb 12, 2024 Direct F3
transaction COLL Common Stock Tax liability -$342K -10.1K -6.38% $33.70 149K Feb 12, 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
F2 Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,286 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
F4 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.